Introduction
Cellular aging emerges from the interplay of genome integrity, stress-response signaling, and macromolecular quality control. Telomeres—repetitive DNA–protein structures at chromosome ends—progressively shorten during replication and become dysfunctional under oxidative and inflammatory stress. When telomere protection erodes, DNA damage signals activate checkpoint pathways that reshape cell fate decisions, including senescence, altered differentiation potential, or programmed elimination. In parallel, autophagy acts as a conserved pathway for cytoplasmic quality control, intersecting with genome surveillance through nucleic acid sensing and p53-dependent transcriptional programs.
Recent preclinical investigations suggest that telomere deprotection can initiate an autophagy-centered death program via cytosolic DNA sensing, while clock-controlled transcription modulates telomerase activity and telomere homeostasis. Converging evidence also indicates that telomere dysfunction influences progenitor cell output in cardiac and neural niches and that telomerase reverse transcriptase (TERT) may have non-canonical, mitochondria- and transcription-linked roles in experimental systems. Mapping these axes—telomere integrity, p53/autophagy crosstalk, and circadian control—may clarify how aging-associated trajectories arise in laboratory models.
Telomere Deprotection, Cytosolic DNA Sensing, and an Autophagy-Driven Crisis Response
Work in engineered human fibroblasts and epithelial cells indicates that telomere crisis can culminate in an autophagy-mediated death program rather than classic apoptosis. Mechanistically, chromosome end fusions and subsequent breakage generate cytosolic DNA that engages cGAS–STING signaling, which appears to transduce a pro-autophagic response in cells that have bypassed senescence through RB and/or p53 pathway suppression. Telomere deprotection induced by TRF2 depletion is sufficient to trigger this response independently of replicative crisis, and genetic reduction of telomere fusions attenuates cytosolic DNA accumulation and autophagy markers. Notably, autophagy-deficient cells—or cells lacking cGAS or STING—can proliferate beyond crisis in vitro, implying that the autophagy arm comprises a final barrier to continued propagation under telomere dysfunction in these experimental settings. These observations position the telomere–cGAS–STING axis as a gatekeeper that couples genome end instability to cytoplasmic catabolic control.
p53 as a Contextual Switch Between Quiescence, Senescence, and Autophagic Remodeling
Short telomeres activate p53, a transcriptional integrator that shapes cell fate across proliferative, quiescent, and senescent states. In cardiac progenitor cell models, telomere attrition biases the system away from reversible arrest toward senescence and basal lineage commitment. Interventions that blunt telomere shortening (e.g., TERT overexpression in vitro), suppress p53, or transiently inhibit autophagy have been reported to mitigate senescence markers and partially restore a less committed state in aged progenitor cultures. These findings suggest a circuit in which telomere-driven p53 activation interfaces with autophagy to remodel progenitor cell behavior—potentially contributing to age-associated stem cell exhaustion observed in experimental preparations.
Circadian Regulation of TERT Transcription and Telomerase Activity
Telomerase activity and TERT mRNA exhibit circadian oscillations in humans and mice, linked to transcriptional control by CLOCK–BMAL1 heterodimers. In clock-deficient mice, rhythmicity in telomerase activity and TERT transcripts is disrupted, coinciding with shorter telomeres. Broader metabolic nodes feed into this clock–telomere circuit: NAD⁺/SIRT1 and AMPK–PGC-1α signaling connect energy state to circadian transcription, while increased reactive oxygen species in circadian mutants correlate with accelerated telomere erosion in laboratory models. These data support a framework in which the molecular clock coordinates genome end maintenance with cellular energetics and redox balance, thereby aligning replication and repair capacity with daily cycles in experimental systems.
Cardiomyocyte Biology Under Telomere Constraint: Structure–Function Consequences
Experimental telomerase ablation and telomere loss in myocardium associate with impaired cell division, increased myocyte death, hypertrophy, and chamber remodeling in mice—features that collectively degrade contractile performance. In correlative studies, shorter telomeres and reduced telomerase activity are observed alongside markers of atherosclerotic plaque instability and are linked to cardiovascular risk factors in observational contexts. Oxidative and inflammatory stressors, frequently elevated in cardiovascular disease models, appear to accelerate telomere attrition, which may restrict regenerative capacity and contribute to systolic or diastolic dysfunction. Within this mechanistic frame, telomere state behaves as an integrated readout of cumulative replicative history and stress exposure.
Non-Canonical TERT Functions: Mitochondrial and Transcriptional Interfaces in Experimental Models
Beyond telomere repeat synthesis, TERT has been implicated in mitochondria-associated and transcription-linked programs. In cardiac stromal and fibroblast models, TERT localization dynamics correlate with anti-apoptotic effects in cardiomyocytes, modulation of myofibroblast differentiation, and endothelial cell migration—responses that intersect with respiratory chain activity and cytoskeletal remodeling. In neurodegeneration models, TERT upregulation has been associated with reduced amyloid-associated signals, dampened neuroinflammation, and activation of SIRT1 and synaptic plasticity–related genes, suggesting telomere-independent transcriptional crosstalk. While these non-canonical activities remain under investigation, they highlight potential routes through which TERT can influence cellular stress tolerance and remodeling apart from telomere elongation.
Neural Stem/Progenitor Cells: Telomere Status, p53–Notch Crosstalk, and Neuritogenesis
In the subependymal zone, telomere shortening has been linked to reduced neurogenesis and impaired neuritogenesis. Evidence points to p53 as a central modulator: removing p53 can rescue proliferation, self-renewal, and differentiation defects in telomerase-deficient mouse models, indicating that deleterious effects of critically short telomeres on adult neurogenesis are largely p53-mediated. At the differentiation interface, p53 cooperates with Notch signaling to upregulate RhoA effectors (ROCK1/2), which negatively regulate neurite extension by tuning actin dynamics. This places telomere-driven p53 activation upstream of cytoskeletal remodeling programs, thereby coordinating genome damage checkpoints with morphogenesis in neural lineages under experimental conditions.
Autophagy as a Double-Edged Integrator: Homeostatic Clearance Versus Programmed Elimination
Autophagy maintains proteostasis and organelle quality, generally antagonizing apoptosis; yet, in specific telomere-damage contexts, autophagy can become the executing arm of crisis-associated death. The cGAS–STING pathway provides a plausible molecular bridge, sensing fusion-induced chromosome fragments in the cytosol and engaging autophagic machinery. In progenitor populations, autophagy may alternatively serve adaptive roles—recycling biomass to sustain function under stress—such that its inhibition produces divergent outcomes depending on context and timing. These nuances underscore the need to resolve temporal sequencing: when autophagy is protective versus when it is the programmed terminal response to telomere catastrophe.
Synthesis and Outlook
Across multiple tissues and model systems, telomere integrity couples to fate decisions through p53 checkpoints, cytosolic DNA sensing, and context-dependent autophagy. Circadian transcription further modulates telomerase activity and oxidative tone, linking daily metabolic cycles to genome end maintenance. Non-canonical TERT activities add layers of regulation at mitochondria and within nuclear transcriptional networks, while specialized niches such as cardiac and neural progenitors reveal how telomere state can steer regeneration and differentiation. Dissecting these intersections with time-resolved, cell-type–specific approaches—single-cell multi-omics, live imaging of cGAS–STING/autophagy dynamics, and subcellular TERT tracking—may clarify causal pathways that shape aging-like phenotypes in experimental systems.
Conclusion
Telomere shortening and deprotection initiate a cascade that engages p53, cGAS–STING, and autophagy, with outcomes that range from controlled remodeling to crisis-associated elimination in laboratory models. Circadian regulators influence TERT transcription and telomerase activity, integrating metabolic status with genome end maintenance. In progenitor and post-mitotic contexts, telomere status and TERT localization intersect with cytoskeletal, mitochondrial, and immune programs that shape functional aging trajectories. The cumulative evidence supports a mechanistic network—rather than a single linear pathway—linking telomere biology to autophagy and tissue-specific outcomes. Further controlled investigations are required to define sufficiency, timing, and context rules across cell states.
References
- Matsumoto, Collin, et al. “Short Telomeres Induce P53 and Autophagy and Modulate Age-Associated Changes in Cardiac Progenitor Cell Fate.” Stem Cells (Dayton, Ohio), 36(6), 2018, 868–880, pubmed.ncbi.nlm.nih.gov/29441645/, 10.1002/stem.2793.
- Yeh, Jih-Kai, and Chao-Yung Wang. “Telomeres and Telomerase in Cardiovascular Diseases.” Genes, 7(9), 2016, 58, 10.3390/genes7090058.
- Kagawa, Yasuo. “From Clock Genes to Telomeres in the Regulation of the Healthspan.” Nutrition Reviews, 70(8), 2012, 459–471, 10.1111/j.1753-4887.2012.00504.x.
- Terai, Masanori, et al. “Association of Telomere Shortening in Myocardium with Heart Weight Gain and Cause of Death.” Scientific Reports, 3(1), 2013, 2401, www.nature.com/articles/srep02401, 10.1038/srep02401.
- Chen, Wei-Dar, et al. “The Circadian Rhythm Controls Telomeres and Telomerase Activity.” Biochemical and Biophysical Research Communications, 451(3), 2014, 408–414, 10.1016/j.bbrc.2014.07.138.
- “Telomerase Alleviates Alzheimer’s Symptoms Not via Telomeres.” Www.lifespan.io, www.lifespan.io/news/telomerase-alleviates-alzheimers-symptoms-not-via-telomeres/.
- Le, Thi Yen Loan, et al. “Enhanced Cardiac Repair by Telomerase Reverse Transcriptase Over-Expression in Human Cardiac Mesenchymal Stromal Cells.” Scientific Reports, 9(1), 2019, 10579, 10.1038/s41598-019-47022-w.
- Zlotorynski, Eytan. “Telomere Crisis Activates Autophagic Death.” Nature Reviews Molecular Cell Biology, 20(3), 2019, 133–133, 10.1038/s41580-019-0105-7.
- Ferrón, Sacri R., et al. “Telomere Shortening in Neural Stem Cells Disrupts Neuronal Differentiation and Neuritogenesis.” The Journal of Neuroscience, 29(46), 2009, 14394–14407, 10.1523/JNEUROSCI.3836-09.2009.
- Leri, Annarosa, et al. “Ablation of Telomerase and Telomere Loss Leads to Cardiac Dilatation and Heart Failure Associated with P53 Upregulation.” The EMBO Journal, 22(1), 2003, 131–139, 10.1093/emboj/cdg013.
Disclaimer: The information provided is intended solely for educational and scientific discussion. The compounds described are strictly intended for laboratory research and in-vitro studies only. They are not approved for human or animal consumption, medical use, or diagnostic purposes. Handling is prohibited unless performed by licensed researchers and qualified professionals in controlled laboratory environments.
